-
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A. Genes Immun. 2025 Dec; 26(6):626. Almeida MA, Diego VP, Viel KR, Luu BW, Haack K, Rajalingam R, Ameri A, Chitlur M, Rydz N, Lillicrap D, Watts RG, Kessler CM, Ramsey C, Dinh LV, Kim B, Powell JS, Manusov EG, Peralta JM, Bouls R, Abraham SM, Shen YM, Murillo CM, Mead H, Lehmann PV, Fine EJ, Escobar MA, Kumar S, Konkle BA, Williams-Blangero S, Kasper CK, Almasy L, Cole SA, Blangero J, Howard TE. PMID: 40999024.
-
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A. Genes Immun. 2025 Jun; 26(3):179-189. Almeida MA, Diego VP, Viel KR, Luu BW, Haack K, Rajalingam R, Ameri A, Chitlur M, Rydz N, Lillicrap D, Watts RG, Kessler CM, Ramsey C, Dinh LV, Kim B, Powell JS, Manusov EG, Peralta JM, Bouls R, Abraham SM, Shen YM, Murillo CM, Mead H, Lehmann PV, Fine EJ, Escobar MA, Kumar S, Konkle BA, Williams-Blangero S, Kasper CK, Almasy L, Cole SA, Blangero J, Howard TE. PMID: 40263602.
-
Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A. Front Genet. 2025; 16:1506862. Diego VP, Luu BW, Almeida MA, Rajalingam R, Hofmann M, Galan JA, Manusov EG, Powell JS, Dinh LV, Mead H, Huynh H, Verhagen AM, Peralta JM, Lehmann PV, Kumar S, Fine EJ, Curran JE, Goring HH, Escobar MA, Williams-Blangero S, Maraskovsky E, Blangero J, Howard TE. PMID: 40270541; PMCID: PMC12016221.
-
Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A. J Thromb Haemost. 2020 01; 18(1):201-216. Diego VP, Luu BW, Hofmann M, Dinh LV, Almeida M, Powell JS, Rajalingam R, Peralta JM, Kumar S, Curran JE, Sauna ZE, Kellerman R, Park Y, Key NS, Escobar MA, Huynh H, Verhagen AM, Williams-Blangero S, Lehmann PV, Maraskovsky E, Blangero J, Howard TE. PMID: 31556206.
-
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):730-8. Klamroth R, Simpson M, von Depka-Prondzinski M, Gill JC, Morfini M, Powell JS, Santagostino E, Davis J, Huth-Kühne A, Leissinger C, Neumeister P, Bensen-Kennedy D, Feussner A, Limsakun T, Zhou M, Veldman A, St Ledger K, Blackman N, Pabinger I. PMID: 27434619.
-
Longer-acting clotting factor concentrates for hemophilia. J Thromb Haemost. 2015 Jun; 13 Suppl 1:S167-75. Powell JS. PMID: 26149018.
-
Placenta as a Source of Stem Cells for Regenerative Medicine. Current Pathobiology Reports. 2015 Mar 1; 3(1):9-16. Meierhenry MJ, Ryzhuk RV, Miguelino MM, Lankford LL, Powell PJ, Farmer FD, Wang WA. .
-
Lasting power of new clotting proteins. Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):355-63. Powell JS. PMID: 25696879.
-
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study. Br J Haematol. 2015 Jan; 168(1):124-34. Powell JS, Apte S, Chambost H, Hermans C, Jackson S, Josephson NC, Mahlangu JN, Ozelo MC, Peerlinck K, Pasi J, Perry D, Ragni MV, Wang X, Jiang H, Li S, Cristiano LM, Innes A, Nugent K, Brennan A, Luk A, Allen G, Pierce GF, Robinson B. PMID: 25208598.
-
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. Br J Haematol. 2015 Jan; 168(1):113-23. Powell J, Shapiro A, Ragni M, Negrier C, Windyga J, Ozelo M, Pasi J, Baker R, Potts J, Li S, Mei B, Pierce GF, Robinson B. PMID: 25209873.
-
Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014 Oct; 7(5):559-71. Ducore JM, Miguelino MG, Powell JS. PMID: 25142322.
-
Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B. Patient Prefer Adherence. 2014; 8:1073-83. Miguelino MG, Powell JS. PMID: 25143713; PMCID: PMC4133029.
-
Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures. Transfusion. 2015 Jan; 55(1):45-50. Janbain M, Nugent DJ, Powell JS, St-Louis J, Frame VB, Leissinger CA. PMID: 25070582.
-
Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia. 2014 May; 20(3):354-61. Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J, LIPLONG Investigators. PMID: 24847524.
-
Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. J Thromb Haemost. 2014 Apr; 12(4):488-96. Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. PMID: 24843882; PMCID: PMC4265842.
-
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12; 369(24):2313-23. Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF, B-LONG Investigators. PMID: 24304002.
-
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood. 2014 Jan 16; 123(3):317-25. Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF, A-LONG Investigators. PMID: 24227821; PMCID: PMC3894491.
-
Molecular approaches for improved clotting factors for hemophilia. Blood. 2013 Nov 21; 122(22):3568-74. Kaufman RJ, Powell JS. PMID: 24065241; PMCID: PMC3837506.
-
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates. Transfusion. 2013 May; 53(5):1143-4. Soucie JM, Monahan PE, Kulkarni R, De Staercke C, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S. PMID: 23659532.
-
Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors. Haemophilia. 2013 May; 19(3):e151-66. Valentino LA, Allen G, Gill JC, Hurlet A, Konkle BA, Leissinger CA, Luchtman-Jones L, Powell J, Reding M, Stine K. PMID: 23374141.
-
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet. 2013 May 01; 22(9):1903-10. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). PMID: 23372042; PMCID: PMC3613165.
-
Molecular approaches for improved clotting factors for hemophilia. Hematology Am Soc Hematol Educ Program. 2013; 2013:30-6. Kaufman RJ, Powell JS. PMID: 24319159.
-
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov; 108(5):913-22. Powell J, Martinowitz U, Windyga J, Di Minno G, Hellmann A, Pabinger I, Maas Enriquez M, Schwartz L, Ingerslev J, LipLong Study Investigators. PMID: 23014711.
-
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion. 2013 Jun; 53(6):1217-25. Soucie JM, De Staercke C, Monahan PE, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Kulkarni R, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S, US Hemophilia Treatment Center Network. PMID: 22998193; PMCID: PMC4519820.
-
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood. 2012 Mar 29; 119(13):3031-7. Powell JS, Josephson NC, Quon D, Ragni MV, Cheng G, Li E, Jiang H, Li L, Dumont JA, Goyal J, Zhang X, Sommer J, McCue J, Barbetti M, Luk A, Pierce GF. PMID: 22223821; PMCID: PMC3646317.
-
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood. 2012 Jan 19; 119(3):666-72. Shapiro AD, Ragni MV, Valentino LA, Key NS, Josephson NC, Powell JS, Cheng G, Thompson AR, Goyal J, Tubridy KL, Peters RT, Dumont JA, Euwart D, Li L, Hallén B, Gozzi P, Bitonti AJ, Jiang H, Luk A, Pierce GF. PMID: 22110246; PMCID: PMC3265197.
-
The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study. Thromb Haemost. 2011 Aug; 106(2):279-88. Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS, Wilate PK Study Investigators. PMID: 21725579.
-
Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag. 2009 Apr; 5(2):391-402. Powell JS. PMID: 19536318; PMCID: PMC2697540.
-
The next generation of anti-haemophilia factor, factor VIII. Long-lasting protection from spontaneous bleeding, are we there yet? Thromb Haemost. 2008 Sep; 100(3):365-6. Powell J. PMID: 18766246.
-
Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines. Haemophilia. 2008 Mar; 14(2):385-6. Walsh CE, Adult Prophylaxis Study Group. PMID: 18201188.
-
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost. 2008 02; 6(2):277-83. Powell JS, Nugent DJ, Harrison JA, Soni A, Luk A, Stass H, Gorina E. PMID: 18039351.
-
Liposomal approach towards the development of a longer-acting factor VIII. Haemophilia. 2007 Sep; 13 Suppl 2:23-8. Powell JS. PMID: 17685920.
-
Reformulated BeneFix: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B. Haemophilia. 2007 May; 13(3):233-43. Lambert T, Recht M, Valentino LA, Powell JS, Udata C, Sullivan ST, Roth DA. PMID: 17498071.
-
Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia. 2005 Sep; 11(5):516-28. Goedert JJ, Second Multicenter Hemophilia Cohort Study. PMID: 16128897.
-
"Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy. Ann Intern Med. 2004 Sep 21; 141(6):W91-2. Pimstone NR, Pimstone D, Saicheur T, Powell J, Yu AS. PMID: 15381541.
-
Long-term correction of hyperglycemia in diabetic mice after implantation of cultured human cells derived from fetal pancreas. Pancreas. 2004 Jul; 29(1):e23-9. Wu F, Jagir M, Powell JS. PMID: 15211120.
-
Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P). Haemophilia. 2004 Jan; 10(1):42-51. Thompson AR, Gill JC, Ewenstein BM, Mueller-Velten G, Schwartz BA, Humate-P Study Group. PMID: 14962219.
-
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy. Haemophilia. 2003 Nov; 9(6):688-95. Gill JC, Ewenstein BM, Thompson AR, Mueller-Velten G, Schwartz BA, Humate-P Study Group. PMID: 14750934.
-
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood. 2003 Sep 15; 102(6):2038-45. Powell JS, Ragni MV, White GC, Lusher JM, Hillman-Wiseman C, Moon TE, Cole V, Ramanathan-Girish S, Roehl H, Sajjadi N, Jolly DJ, Hurst D. PMID: 12763932.
-
The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002 Jan; 87(1):52-7. DiMichele DM, Kroner BL, North American Immune Tolerance Study Group. PMID: 11848456.
-
Lead arthropathy and systemic lead poisoning from an intraarticular bullet. AJR Am J Roentgenol. 2001 May; 176(5):1144. DeMartini J, Wilson A, Powell JS, Powell CS. PMID: 11312168.
-
Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia. 2001 May; 7(3):235-41. Cohen AJ, Kessler CM, Ewenstein BM, Hemophilia Research Society of North America. PMID: 11380626.
-
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group. Thromb Haemost. 2000 Jun; 83(6):811-6. Abshire TC, Brackmann HH, Scharrer I, Hoots K, Gazengel C, Powell JS, Gorina E, Kellermann E, Vosburgh E. PMID: 10896230.
-
Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000 May; 6(3):140-9. Powell JS, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson AR, Hurst D. PMID: 10792471.
-
Novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn. 1998 Sep; 45(1):82-8; discussion 90-1. Gershony G, Brock JM, Powell JS. PMID: 9736360.
-
Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies. Thromb Haemost. 1996 Dec; 76(6):998-1003. Levin LG, Jarvis M, Powell J, Harrison JA, Reisner HM. PMID: 8972024.
-
Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. Biotechnol Appl Biochem. 1996 06; 23(3):217-20. Mack KD, Walzem RL, Lehmann-Bruinsma K, Powell JS, Zeldis JB. PMID: 8679107.
-
Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype. Thromb Haemost. 1996 Feb; 75(2):318-25. Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS. PMID: 8815584.
-
Hepatic gene expression after direct DNA injection. Advanced Drug Delivery Reviews. 1995 Dec 1; 17(3):265-271. Hickman HM, Malone MR, Sih ST, Akita AG, Carlson CD, Powell PJ. .
-
Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochem Biophys Res Commun. 1995 Feb 06; 207(1):348-54. Burke PA, Lehmann-Bruinsma K, Powell JS. PMID: 7857288.
-
Gene expression following direct injection of DNA into liver. Hum Gene Ther. 1994 Dec; 5(12):1477-83. Hickman MA, Malone RW, Lehmann-Bruinsma K, Sih TR, Knoell D, Szoka FC, Walzem R, Carlson DM, Powell JS. PMID: 7711140.
-
Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J Biol Chem. 1994 Nov 25; 269(47):29903-7. Malone RW, Hickman MA, Lehmann-Bruinsma K, Sih TR, Walzem R, Carlson DM, Powell JS. PMID: 7961986.
-
Effect of cilazapril on the proliferative response after vascular damage. J Cardiovasc Pharmacol. 1993; 22 Suppl 4:S19-24. Lehmann K, Powell JS. PMID: 7523769.
-
Heparin and cilazapril together inhibit injury-induced intimal hyperplasia. Hypertension. 1991 Oct; 18(4 Suppl):II65-9. Clowes AW, Clowes MM, Vergel SC, Müller RK, Powell JS, Hefti F, Baumgartner HR. PMID: 1833326.
-
Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991 Oct; 18(4 Suppl):II60-4. Osterrieder W, Müller RK, Powell JS, Clozel JP, Hefti F, Baumgartner HR. PMID: 1833325.
-
Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991 Oct; 18(4 Suppl):II70-6. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. PMID: 1833327.
-
Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):137B-142B. Powell JS, Muller RK, Baumgartner HR. PMID: 1826694.
-
Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res Cardiol. 1991; 86 Suppl 1:65-74. Powell JS, Rouge M, Müller RK, Baumgartner HR. PMID: 1827985.
-
Vascular protection with cilazapril. Drugs. 1991; 41 Suppl 1:62-7. Clozel JP, Powell JS, Kuhn H, Müller RK, Hefti F, Baumgartner HR. PMID: 1712274.
-
Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int. 1990 Nov; 38(5):969-75. Mason-Garcia M, Beckman BS, Brookins JW, Powell JS, Lanham W, Blaisdell S, Keay L, Li SC, Fisher JW. PMID: 2266682.
-
Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor A-chain homodimer. Cell Regul. 1990 Oct; 1(11):821-31. Resink TJ, Scott-Burden T, Hahn AW, Rouge M, Hosang M, Powell JS, Bühler FR. PMID: 1965150; PMCID: PMC362849.
-
Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990 Aug; 1(9):649-59. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR. PMID: 2078571; PMCID: PMC361629.
-
Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 May 16; 168(3):1303-10. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Bühler FR. PMID: 2161221.
-
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 1990; 16 Suppl 4:S42-9. Powell JS, Müller RK, Rouge M, Kuhn H, Hefti F, Baumgartner HR. PMID: 1705627.
-
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 Jul 14; 245(4914):186-8. Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. PMID: 2526370.
-
Selective expression of mRNA encoding platelet-derived growth factor B chain following transfection of foreign genes into cell lines derived from baby hamster kidney. J Cell Biochem. 1989 Jan; 39(1):87-94. Sakariassen KS, Powell JS, Raines EW, Ross R. PMID: 2654148.
-
Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem. 1988 Nov 25; 263(33):17516-21. Dubé S, Fisher JW, Powell JS. PMID: 3182860.
-
Recombinant human erythropoietin: purification and analysis of carbohydrate linkage. Arch Biochem Biophys. 1988 Sep; 265(2):329-36. Broudy VC, Tait JF, Powell JS. PMID: 3421710.
-
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest. 1987 Apr; 79(4):1153-9. Bernstein ID, Singer JW, Andrews RG, Keating A, Powell JS, Bjornson BH, Cuttner J, Najfeld V, Reaman G, Raskind W, et al. PMID: 3470307; PMCID: PMC424297.
-
Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. PMID: 3098093.
-
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood. 1986 Nov; 68(5):1030-5. Andrews RG, Takahashi M, Segal GM, Powell JS, Bernstein ID, Singer JW. PMID: 3768529.
-
Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci U S A. 1986 Sep; 83(17):6465-9. Powell JS, Berkner KL, Lebo RV, Adamson JW. PMID: 3462706; PMCID: PMC386524.
-
Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. PMID: 3085703.
-
Hematopoietic growth factors in human serum. erythroid burst-promoting activity in normal subjects and in patients with severe aplastic anemia. J Lab Clin Med. 1985 Oct; 106(4):384-92. Yen YP, Zabala P, Doney K, Clemons G, Gillis S, Powell JS, Adamson JW. PMID: 4045296.
-
Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. J Clin Invest. 1985 Jul; 76(1):137-42. Delwiche F, Raines E, Powell J, Ross R, Adamson J. PMID: 4019772; PMCID: PMC423728.
-
The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood. 1984 Dec; 64(6):1159-62. Keating A, Powell J, Takahashi M, Singer JW. PMID: 6594169.
-
A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell. N Engl J Med. 1984 Jun 07; 310(23):1513-7. Jacobson RJ, Temple MJ, Singer JW, Raskind W, Powell J, Fialkow PJ. PMID: 6717542.
-
Human mixed cell colonies: unicellular or multicellular origin--analysis by G-6-PD. Br J Haematol. 1984 May; 57(1):89-95. Powell JS, Fialkow PJ, Adamson JW. PMID: 6722041.
-
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leuk Res. 1984; 8(4):535-45. Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, Moohr JW, Najfeld V, Powell J, Sanders J, et al. PMID: 6471898.
-
Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol. 1984 Jan; 118(1):87-96. Kimura H, Burstein SA, Thorning D, Powell JS, Harker LA, Fialkow PJ, Adamson JW. PMID: 6690455.
-
The spleen as a source of colony-forming cells in myelofibrosis. Prog Clin Biol Res. 1984; 154:323-34. Adamson JW, Powell JS. PMID: 6382301.
-
High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med. 1983 Oct; 102(4):613-20. Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW. PMID: 6311928.
-
Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl. 1982; 1:79-85. Powell JS, Fialkow PJ, Adamson JW. PMID: 6950947.
US